Resistance to linezolid in staphylococcus aureus before its release;Résistance au linézolide de Staphylococcus aureus avant inscription au livret du médicament

Pathologie Biologie

Volumn 52, Issue 8, 2004, Pages 493-496

  Akpabie, A ^a   Naga, H ^a   Giraud, K ^a   Al Rahiss, R ^a   Nadai, S ^a  

^a Hôpitaux Universitaires Henri Mondor   (France)

Author keywords

Lin zolide; Linezolid; Oxazolidinone; R sistance; Resistance; Staphylococcus aureus

Indexed keywords

COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; METICILLIN; PEFLOXACIN; RIFAMPICIN; TOBRAMYCIN;

ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; DIFFUSION; DRUG RESISTANCE; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ACETAMIDES; AGED; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCUS AUREUS;

EID: 4744370974     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.07.028     Document Type: Article

References (21)

1. Enqute nationale de prvalence 2001 Rsultats 2003 Maulde et Renou Paris
2. Comité de l'antibiogramme de la société française de microbiologie (CA-SFM), éd. Communiqué 2003. Available from: URL: http://www.sfm.asso.fr.
3. J.A. Karlowski, L.J. Kelly, I.A. Critchley, M.E. Jones, C. Thornsberry, and D.F. Sahm Determining linezolids baseline in vitro activity in Canada using Gram-positive clinical isolates collected prior to its national release Antimicrobial Agents Chemother. 46 2002 1989 1992
4. J.M. Bell, J.D. Turnidge, C.H. Ballow, and R.N. Jones Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific J. Antimicrob. Chemother. 51 2003 339 345
5. C. Muller-Serieys, H.B. Drugeon, J. Etienne, C. Lascols, R. Leclercq, and J. Nguyen Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods Clin. Microbiol. Infect. 10 2004 242 246
6. H.B. Kim, H.C. Jang, H.J. Nam, Y.S. Lee, B.S. Kim, and W.B. Park In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey Antimicrob. Agents Chemother. 48 2004 1124 1127
7. S. Metallidis, M. Chatzidimitriou, P. Nikolaidis, A. Tsona, A. Bisiklis, and P. Kollaras Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillinresistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium J. chemother. 15 2003 442 448
8. J.L. Munoz Bellido, M.N. Gutierrez Zufiaurre, F.J. Sanchez Hernandez, G. Yague Guirao, M. Segovia Hernandez, and J.A. Garcia-Rodriguez In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus Int. J. Antimicrob. Agents 20 2002 61 64
9. S. Stefani, M.L. Mezzatesta, G. Tempera, E. Debbra, A.M. Schito, and G. Nicoletti Comparative activity of linezolid against staphylococci and enterococci isolated in Italy Clin. Microb. Infect. 8 2002 368 372
10. F. Tubau, R. Fernandez-Roblas, J. Linares, R. Martin, and F. Soriano In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods J. Antimicrob. Chemother. 47 2001 675 680
11. D.J. Diekema, and R.N. Jones Oxazolidinone antibiotics Lancet 358 2001 1975 1982
12. R.N. Jones, C.H. Ballow, and D.J. Biedenbach Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States Diagn. Microbiol. Infect. Dis. 40 2001 59 66
13. A. Wookey, P.J. Turner, J.M. Greenhalgh, M. Eastwood, J. Clarke, and C. Sefton AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro Clin. Microb. Infect. 10 2004 247 254
14. R. Wyse, J.M. Andrews, F.J. Boswell, and J.P. Ashby The in-vitro activity of linezolid (U-100766) and tentative breakpoints J. Antimicrob. Chemother. 42 1998 721 728
15. C. Cuny, and W. Witte In vitro activity of linezolid against staphylococci Clin. Microbiol. Infect. 6 2000 331 333
16. G.E. Zurenko, B.H. Yagi, R.D. Schaadt, J.W. Allison, J.O. Kilburn, and S.E. Glickman In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents Antimicrob. Agents Chemother. 40 1996 839 845
17. P. Wilson, J.A. Andrews, R. Charlesworth, R. Walesby, M. Singer, and D.J. Farrell Linezolid resistance in clinical isolates of Staphylococcus aureus J. Antimicrob. Chemother. 51 2003 186 188
18. S. Tsiodras, H.S. Gold, G. Sakoulas, G.M. Eliopoulos, C. Wennersten, and L. Venkataraman Linezolid resistance in a clinical isolate of Staphylococcus aureus Lancet 358 2001 207 208
19. L. Xiong, P. Kloss, S. Douthwaite, N.M. Andresen, S. Swaney, and D.L. Shinabarger Oxazolidinone resistance mutatations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action J. Bacteriol. 182 2000 5325 5331
20. S.M. Swaney, H. Aoki, M.C. Ganoza, and D.L. Shinabarger The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria Antimicrob. Agents Chemother. 42 1998 3251 3255
21. A.H. Lin, R.W. Murray, T.J. Vidmar, and K.R. Marotti The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin Antimicrob. Agents Chemother. 41 1997 2127 2131